Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1186 AL 1200

MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond

Vance JE.

Biochim Biophys Acta. 2014 Apr 4;1841(4):595-609. doi: 10.1016/j.bbalip.2013.11.014. Epub 2013 Dec 6.

Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures

Chakroborty S, Stutzmann GE.

Eur J Pharmacol. 2014 Sep 15;739:83-95. doi: 10.1016/j.ejphar.2013.11.012. Epub 2013 Dec 6.

A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease

Savelieff MG, Liu Y, Senthamarai RR, Korshavn KJ, Lee HJ, Ramamoorthy A, Lim MH.

Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.

Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study

Michael R, Otto C, Lenferink A, Gelpi E, Montenegro GA, Rosandić J, Tresserra F, Barraquer RI, Vrensen GF.

Exp Eye Res. 2014 Feb;119:44-53. doi: 10.1016/j.exer.2013.11.016. Epub 2013 Dec 12.

Abnormal kalirin signaling in neuropsychiatric disorders

Remmers C, Sweet RA, Penzes P.

Brain Res Bull. 2014 Apr;103:29-38. doi: 10.1016/j.brainresbull.2013.12.006. Epub 2013 Dec 12.

Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease

Nilsen LH, Melø TM, Witter MP, Sonnewald U.

Neurochem Res. 2014 Feb;39(2):305-12. doi: 10.1007/s11064-013-1222-x. Epub 2013 Dec 17.

Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease

El-Malah A, Gedawy EM, Kassab AE, Salam RM.

Arch Pharm (Weinheim). 2014 Feb;347(2):96-103. doi: 10.1002/ardp.201300121. Epub 2013 Dec 16.

Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta

Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z.

Neurosci Bull. 2014 Feb;30(1):162-8. doi: 10.1007/s12264-013-1391-2. Epub 2013 Dec 19.

Electronic organiser and Alzheimer's disease: fact or fiction?

Imbeault H, Bier N, Pigot H, Gagnon L, Marcotte N, Fulop T, Giroux S.

Neuropsychol Rehabil. 2014;24(1):71-100. doi: 10.1080/09602011.2013.858641. Epub 2013 Dec 23.

Tau-aggregation inhibitor therapy for Alzheimer's disease

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.

A caregiver's wish list for a National Alzheimer's Agenda

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):111-3. doi: 10.1177/1533317513511292. Epub 2013 Dec 26.

The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer's Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers

Santos S, Castanho M.

Am J Alzheimers Dis Other Demen. 2014 Jun;29(4):320-5. doi: 10.1177/1533317513517046. Epub 2013 Dec 26.

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte SM, Tong M.

Biochem Pharmacol. 2014 Apr 15;88(4):548-59. doi: 10.1016/j.bcp.2013.12.012. Epub 2013 Dec 28.

Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo

Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8. Epub 2013 Dec 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias